{'fraction_non_alphanumeric': 0.019855595667870037, 'fraction_numerical': 0.01263537906137184, 'mean_word_length': 5.060109289617486, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Rous sarcoma recurrence and Rous sarcoma virus growth in chicken muscle

Following Rous sarcoma virus (RSV‐Bryan standard strain) infection and tumor regression in chickens, tumors recurred in 3 of 6 chickens after contralateral inoculation of 105 of RSV. In an attempt to understand the mechanism of tumor recurrence, chickens which had recovered from RSV infection were inoculated at the regression site with Rous associated virus (RAV). Tumors recurred in one‐third of those chickens that received three bi‐weekly RAV injections and in one chicken that received only a single RAV injection. The tumors re‐appeared from 6 to 19 weeks after regression of the original tumors and within 4 weeks of the last RAV challenge. RSV was recovered from cultures of a recurring tumor as well as from a wing that developed subcutaneous blistering following RAV inoculations. RSV was also obtained from 40% of “recovered” wing muscles explanted in tissue culture up to 3 months after regression. In addition, RSV was isolated from a tumor that recurred in one of 12 recovered chickens inoculated with Freund's adjuvant.